To further determine the role of TIMP‐3 in inhibiting invasiveness of mAb NJ001‐treated lung AD cells, we developed SPC‐A1 cells with endogenous TIMP‐3 knockdown, using shTIMP‐3. Here, TIMP3 is linked to medical procedure.